JK

Jyoti Kumari

Active Director Director DIN 08439842
DIN 08439842 First appointment May 2019 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since May 2019
Shareholding value Locked Premium profile

About Jyoti Kumari

Jyoti Kumari has 7 years in corporate governance. Holds Director role. Currently with 1 company, including Jirel Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 08439842
Primary Designation Director
First Appointment 01 May 2019
Oldest Company Age 7 yrs

Current companies

Company Designation Appointment Founded Status
Director 01 May 2019 2019 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Jirel Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Jyoti Kumari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jyoti Kumari

Jyoti Kumari has 7 years in corporate governance. Holds Director role. Currently with 1 company, including Jirel Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Jyoti Kumari is associated with 1 company as Director.

Jyoti Kumari has expertise in General Business.

Jyoti Kumari has 7 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available